The SMA News Today Podcast Episode 20: Roundtable Discussion of AVXS-101
In this episode of the SMA News Today Podcast, I talk with Forums Director Michael Morale about the pharmaceutical company AveXis, and its recent filing for FDA approval of the therapy AVXS-101. This treatment is designed for infants with SMA Type I.
During this discussion, Michael and I talk about when this treatment could be made available, if it will eventually be available for adults with SMA, what it means for SMA patients who are already on Spinraza (nusinersen), and what other treatments for SMA are in development.
Michael and I will be doing these roundtable discussions monthly, and we will tackle a wide range of subjects pertaining to the SMA community. Be sure to subscribe to the SMA News Today Podcast, and share your thoughts in the comments.
Sorry, there were no replies found.
Log in to reply.